Clarkson plc CKN Despite a challenging start to the year Clarkson produced a robust performance for the year to the end of December.Underlying profit before tax fell by 10% and earnings per share declined from 116p to 105p.The CEO is happy with this as it enables the dividend to be increased by 3% making it the16th consecutive year of increased dividends. Headwinds are having their impact in the form of political uncertainty and natural disasters but these are expected to diminish as the year passes.
Polymetal International POLY Preliminaries to the 31st December showed that 2018 was a year of strong operating and financial results,with revenue rising by 4% and gold sales up by 10$. Adjusted EBITDA was up by 5%, although average realised gold and silver prices both fell. A final dividend of US$ .31 is proposed. The dividend declared during the period has risen by 47% from last years 32 cents to the current 47 cents.
Xaar plc XAR updates that underlying trading results for the year to 31 December 2018 are in line with previous expectations and delays in ramp up of new product volumes in China have resulted in an unfavourable aging profile of working capital. Provisions are therefore being taken on the basis of prudency.
Silence Therapeutics plc SRN updates that 2018 was a defining year for the company, with transformational change throughout the business. With the approval by the FDA of the first RNAi therapeutics, a new class of medicines has effectively been created. In-human clinical trials are due to commence later in 2019 to demonstrate both safety and tolerability. The interim Chair of Silence describes it as being at the cutting edge of an extremely promising new class of therapeutics.
Driver Group plc DRV reports that the cumulative trading result is now behind the Board’s expectations for the current period due to a slowing in the speed of client conversion, in particular in the Middle East and south-east Asian markets. The cumulative trading result is now behind the Board’s expectations for the current period and the shortfall is unlikely to be recovered in the second half. Full year underlying profits before taxation are now expected to be slightly below the 2017/18 result at approximately £3.5m.